RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer

David Guerrero‐Setas; Noemí Pérez‐Janices; Laura Blanco; Amaya Ojer; Koldo Cambra; María Berdasco; Manel Esteller; Sergio Maria‐Ruiz; Natalia Torrea; Rosa Guarch

doi:10.1038/modpathol.2013.32

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1994

Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991

Fabio Levi, Carlo La Vecchia, Lalao Randimbison, V.-C. Te

Article2016

Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer

Anna Martínez‐Cardús, Sebastián Morán, Eva Musulén, Cátia Moutinho, José Luís Manzano, Eva Martinez‐Balibrea, Montserrat Tierno, Elena Élez, Stefania Landolfi, Patricia Lorden, Carles Arribas, Fabian Müller, Christoph Bock, Josep Tabernero, Manel Esteller

Article2006

Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy

Sílvia Marcé, Olga Balagué, Luís Colomo, Antonio Martı́nez, Sylvia Höller, Neus Villamor, Francesc Bosch, German Ott, Andreas Rosenwald, Lorenzo M. Leoni, Manel Esteller, Mario F. Fraga, Emili Montserrat, Dolors Colomer, Elı́as Campo

Article2014

Obesity in Childhood and Adolescence is Associated with Shorter Leucocyte Telomere Length

Agaristi Lamprokostopoulou, George Moschonis, Yannis Μanios, George Chrousos, Evangelia Charmandari

Article2002

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

Manel Esteller